AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...
Plants are constantly exposed to a wide array of biotic and abiotic stresses in their natural environments, posing ...
What if the thermal noise that hinders the efficiency of both classical and quantum computers could, instead, be used as a ...
Artificial intelligence (AI)-driven investment strategies could help pension schemes improve risk-adjusted returns without increasing portfolio risk, according to SmartWealth Asset Management AG CEO, ...
Overview AI medical diagnosis can recognize disease patterns even before symptoms worsenPredictive healthcare models delve into risk factors over the long termM ...
A new Nature Aging study shows that simple blood tests can detect Alzheimer's and frontotemporal dementia with up to 96% accuracy in Latin American populations — genetically diverse groups that have ...
Glucose dysregulation may drive cerebral small vessel disease progression through microstructural brain damage, according to ...
Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability ...
Researchers from Duke Health and the University of Minnesota recently discovered that measuring specific tiny genetic ...
This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A ...
Researchers have developed a diagnostic panel that identifies cognitive decline by analyzing how blood proteins fold. This ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results